ARCHIVES

NCI To Require Reports On Adverse Drug Reactions From Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 23 | June 10, 1994

Download PDF Visit The Full Archive

Related Articles

IARC Director Denies NCI Staff Interference With Monograph

May 28, 1982

Ohio State Schedules Workshop On CCOP

February 5, 1982

Waxman Introduces NIH Reauthorization, Kennedy To Follow

April 26, 1991

Appropriations 2013: Obama Proposes Flat Funding for NIH

February 17, 2012

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

Weicker Compromise on 6,000 Grants For Two Years Holds Up; New Waxman Bill Would Renew Cancer Act

May 17, 1985